MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41467-024-45806-x

Медицинская библиотека · Nature communications · 2024

Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection.

Santos-Peral Antonio, Luppa Fabian, Goresch Sebastian, Nikolova Elena, Zaucha Magdalena, Lehmann Lisa, Dahlstroem Frank, Karimzadeh Hadi, Thorn-Seshold Julia, Winheim Elena, Schuster Ev-Marie, Dobler Gerhard, Hoelscher Michael, Kümmerer Beate M, Endres Stefan, Schober Kilian, Krug Anne B, Pritsch Michael, Barba-Spaeth Giovanna, Rothenfusser Simon

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

The yellow fever 17D vaccine (YF17D) is highly effective but is frequently administered to individuals with pre-existing cross-reactive immunity, potentially impacting their immune responses. Here, we investigate the impact of pre-existing flavivirus immunity induced by the tick-borne encephalitis virus (TBEV) vaccine on the response to YF17D vaccination in 250 individuals up to 28 days post-vaccination (pv) and 22 individuals sampled one-year pv. Our findings indicate that previous TBEV vaccination does not affect the early IgM-driven neutralizing response to YF17D. However, pre-vaccination sera enhance YF17D virus infection in vitro via antibody-dependent enhancement (ADE). Following YF17D vaccination, TBEV-pre-vaccinated individuals develop high amounts of cross-reactive IgG antibodies with poor neutralizing capacity. In contrast, TBEV-unvaccinated individuals elicit a non-cross-reacting neutralizing response. Using YF17D envelope protein mutants displaying different epitopes, we identify quaternary dimeric epitopes as the primary target of neutralizing antibodies. Additionally, TBEV-pre-vaccination skews the IgG response towards the pan-flavivirus fusion loop epitope (FLE), capable of mediating ADE of dengue and Zika virus infections in vitro. Together, we propose that YF17D vaccination conceals the FLE in individuals without prior flavivirus exposure but favors a cross-reactive IgG response in TBEV-pre-vaccinated recipients directed to the FLE with potential to enhance dengue virus infection.

Для цитирования: Santos-Peral Antonio, Luppa Fabian, Goresch Sebastian, Nikolova Elena, Zaucha Magdalena, Lehmann Lisa, Dahlstroem Frank, Karimzadeh Hadi, Thorn-Seshold Julia, Winheim Elena, Schuster Ev-Marie, Dobler Gerhard, Hoelscher Michael, Kümmerer Beate M, Endres Stefan, Schober Kilian, Krug Anne B, Pritsch Michael, Barba-Spaeth Giovanna, Rothenfusser Simon. Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection.. Nature communications. 2024. DOI: 10.1038/s41467-024-45806-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.